Bio Pharma Dive
MAY 21, 2023
The safety risks of obeticholic acid were too great for an advisory committee to recommend approval without clear proof of its benefits. But collecting that data may not be “economically feasible,” an executive said.
AuroBlog - Aurous Healthcare Clinical Trials blog
MAY 21, 2023
Over 55 million people worldwide have dementia. This mind-robbing condition has a huge impact on society and the economy, so scientists are working hard to find ways to treat or prevent it. One of the avenues being explored is the new weight-loss jab, Wegovy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
BioSpace
MAY 21, 2023
Krystal Gets First FDA Approval for Redosable Gene Therapy, Rare Skin Disease 5/22/2023
AuroBlog - Aurous Healthcare Clinical Trials blog
MAY 21, 2023
The Union Ministry of Ayush has submitted in the Delhi High Court that it has instructed the licensing authority for the Ayush systems of medicines in all the States and Union Territories that they should ensure that the labelling and naming of the products for the Ayurvedic and Unani drugs should be as per the […]
Advertisement
There’s been a rapid shift towards decentralization in clinical trials & it’s clear why. The potential for reaching a larger pool of recruits is possible when sponsors can bring more trial activities to the patient. Tele visits, digital consent, new monitoring sensors, & direct-to-patient supply are virtual tools that existed before the pandemic, but now there’s swift adoption of these methods because they’ve been proven to help launch & complete trials more effectively.
BioSpace
MAY 21, 2023
Biopharma Targets the Untapped Potential of the Human Healthspan 5/22/2023
pharmaphorum
MAY 21, 2023
FDA clears Vyjuvek as first topical gene therapy Phil.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Drug Patent Watch
MAY 21, 2023
SELZENTRY (maraviroc) Viiv hlthcare Patent: 7,368,460 Expiration: May 25, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or… The post Drug Patent Expirations for the Week of May 21, 2023 appeared first on DrugPatentWatch - Make Better Decisions.
BioSpace
MAY 21, 2023
Hepion Claims Phase II NASH Victory Following Intercept’s Adcomm Defeat 5/22/2023
JAMA Internal Medicine
MAY 21, 2023
This cohort study uses commercial insurance claims to compare the incidence of first moderate or severe chronic obstructive pulmonary disease (COPD) exacerbation and first pneumonia hospitalization among patients with COPD who started using inhalers with long-acting muscarinic antagonists and long-acting β-agonists (LABAs) vs inhalers containing inhaled corticosteroids and LABAs.
BioSpace
MAY 21, 2023
AbbVie, Genmab Score FDA Nod for DLBCL as Blood Cancer Space Heats Up 5/22/2023
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
JAMA Internal Medicine
MAY 21, 2023
This randomized clinical trial evaluates kidney function with the use of medications added to metformin treatment in patients with type 2 diabetes.
BioSpace
MAY 21, 2023
ReCode–a New Contestant in the mRNA Race 5/22/2023
pharmaphorum
MAY 21, 2023
CD20 market heats up as FDA OKs AbbVie, Genmab bispecific Phil.
BioSpace
MAY 21, 2023
Opinion: Sarepta Enters Uncharted Territory with Adcomm Approval 5/22/2023
Advertiser: FourKites
A research study conducted by The Journal of Commerce and FourKites surveyed hundreds of international shippers, exploring how their usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19. For international shippers, ocean freight visibility has evolved from optional to essential and satisfaction with visibility varies greatly depending on how it is obtained and delivered.
Drug Patent Watch
MAY 21, 2023
This chart shows the drugs with the most patents in Philippines. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… The post Which pharmaceutical drugs have the most drug patents in Philippines? appeared first on DrugPatentWatch - Make Better Decisions.
BioSpace
MAY 21, 2023
FDA Action Alert: Blueprint, Opiant and Lexicon 5/22/2023
Expert insights. Personalized for you.
195 
Let's personalize your content